Skip to content

AviClearRecalls & reported problems

Cutera, Inc. · AviClear Laser System · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00816722021700), received between Nov 29, 2025 and Nov 29, 2025 — classified as 1 injury.

The most frequently reported specific device problem is “Improper or Incorrect Procedure or Method” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Improper or Incorrect Procedure or Method1

Patient problems

  • Partial thickness (Second Degree) Burn1
  • Scar Tissue1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 29, 2025Improper or Incorrect Procedure or Method; Improper or Incorrect Procedure or Method

    THE DEVICE OPERATOR USED THE 7-SPOT ARRAY TO TREAT THE SIDE OF THE NOSE (THE NASAL ALAR CREASE). THE AVICLEAR INSTRUCTIONS FOR USE CLEARLY STATE THAT THIS AREA SHOULD NOT BE TREATED. USING THE DEVICE IN THIS SPOT IS CONSIDERED USER ERROR. THE SHAPE OF THE NASAL CREASE MAKES IT HARD TO COOL THE SKIN PROPERLY BEFORE, DURING, AND AFTER THE LASER PULSE, WHICH INCREASES THE CHANCE OF A BURN IF THE AREA IS TREATED. THE PATIENT WHO RECEIVED THE AVICLEAR TREATMENT ALSO SUBMITTED A VOLUNTARY REPORT TO THE FDA (MW5177086), CHARACTERIZING THE INJURY AS A "THIRD-DEGREE BURN." THE TREATING CLINIC DESCRIBED THE INJURY AS A "SECOND-DEGREE BURN." BURNS AND SCARRING ARE IDENTIFIED IN THE AVICLEAR IFU AS KNOWN POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH THE PROCEDURE. NO CUTERA PERSONNEL WERE PRESENT DURING THE TREATMENT, AND CUTERA WAS NOT INVOLVED IN THE EVALUATION, CLINICAL MANAGEMENT, OR DECISION-MAKING REGARDING PATIENT CARE. ON (B)(6) 2025, THE CLINIC REPORTED THAT THE TREATMENT-RELATED BURN WAS "HEALING NICELY." AT THAT TIME, THE ONLY MEDICAL INTERVENTION PROVIDED WAS TOPICAL "SILVER SULFADIAZINE", WHICH IS STANDARD WOUND CARE FOR PARTIAL-THICKNESS BURNS. ON (B)(6) 2025, THE CLINIC AGAIN CONFIR

    Patient problems: Partial thickness (Second Degree) Burn; Scar Tissue

    MAUDE report 23675905 ↗

Other Powered Laser Surgical Instrument devices

All Powered Laser Surgical Instrument devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.